HOME >> BIOLOGY >> NEWS
2002 Ocean Sciences Meeting - Media Advisory 1

The world's largest gathering of ocean scientists takes place this year February 11 to 15 in Honolulu, Hawaii. Sponsored jointly by the American Geophysical Union (AGU) and the American Society of Limnology and Oceanography (ASLO), the 2002 Ocean Sciences Meeting includes 173 sessions and 2,221 individual presentations on a wide variety of topics. Important new research results will be presented to scientists and the media about the least explored and least understood part of our planet, the oceans.

Press Room and press conferences

AGU will hold press conferences on some of the important new research results to be presented at the meeting. These will be announced in a subsequent advisory. Reporters unable to come to Honolulu will be able to participate in these press conferences via a conference call system.

The Press Room is Room 325A of the Hawaii Convention Center. It will be equipped with phone lines (no charge for business calls), a copier, fax, and computer with Internet access. Press releases on research presented at the meeting will be available. Continental breakfast and lunch will be served for press registrants.

The Press Room telephone and fax numbers will be provided in a subsequent advisory, as will procedures for participating in press conferences by phone.

Abstracts now online, later printed and on CD-ROM

Abstracts for the meeting are already online (see below) and will be available in book and CD-ROM form closer to the meeting date. Both the online and CD-ROM versions are searchable by subject, author, institution, or geographic location. Reporters and public information officers must register to attend the meeting or receive abstracts.

URLs for meeting information

Complete information about Ocean Sciences Meeting, along with links to tourism sites, is available online. Some key URLs follow.

* Main web site for meeting information:

Contact: Harvey Leifert
hleifert@agu.org
202-777-7507
American Geophysical Union
14-Jan-2002


Page: 1 2 3 4

Related biology news :

1. What actually influences air pollution over the Indian Ocean?
2. Ocean scientists assess impact of seismic pulses in effort to protect whales
3. Melting ice cap gives urgency to new census of marine life project in Arctic Ocean
4. Ocean dye to help Rutgers scientists trace Hudson Rivers path miles into the Atlantic
5. Gulf of Maine Ocean Data Partnership announced
6. New Woods Hole Center for Oceans and Human Health established
7. Five Marine Conservation leaders receive worlds top award from Pew Institute for Ocean Science
8. Ocean life depends on single circulation pattern in Southern Hemisphere
9. Ocean plant life slows down and absorbs less carbon
10. International meeting on the Southern Ocean
11. Ocean policies havent kept up with science

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ocean Sciences Meeting Media Advisory

(Date:5/21/2013)... Illinois at Chicago College of Medicine will study gender differences ... main energy source -- and how changes in fat metabolism ... million, 4-year grant from the National Heart, Lung and Blood ... fuel for energy. These changes may play a major role ... men and women, says E. Douglas Lewandowski, director of the ...
(Date:5/21/2013)... few decades, scientists have developed many devices that can ... While generally effective, each of these treatments has drawbacks, ... study from MIT analyzes the potential usefulness of a ... and drug-releasing stents, but may pose fewer risks. With ... artery for only a brief period, during which it ...
(Date:5/21/2013)... 2013 Royal Philips Electronics (NYSE: PHG, AEX: ... portable ultrasound with Philips, industry leading Live 3D TEE, ... xMATRIX with available Live 3D TEE and ICE will ... the EuroPCR, official meeting for the European Association of ... its launch in 2012, Philips CX50 xMATRIX has been ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
(Date:5/21/2013)... -- First patients dosed with PSX1002, an ... using Prosonix, particle engineering platform Prosonix, an ... Respiratory Medicines by Design , has initiated a ... its effect on lung function and the safety of ... severe chronic obstructive pulmonary disease (COPD). The first two ...
(Date:5/21/2013)... by George Washington University Professor Tianshu Li provide ... small droplets is strongly size-dependent, an important conclusion ... formation of ice at the nanoscale is a ... has important implications for climate research and other ... supercooled water is generally initiated by a process ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, innovative ... Genzyme, a Sanofi company and leading biotech company, recently ... a multi-use facility in the United States. With Door ... this latest order underscores the satisfaction and success the ... device improving doorway access control. , “We recommend ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: